Boehringer Ingelheim Vetmedica, Inc. announced their first sponsored Equine Research Awards, which were designed to support veterinary research that results in insights or treatments for equine diseases.
The awards are open to U.S. and Canadian veterinarians, diagnosticians and public and private researchers to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine diseases. Boehringer Ingelheim will provide three $25,000 awards to fund the selected research proposals.
The award, projected to become an annual event, will focus on a specific equine disease each year. For 2011, the equine disease of focus is Equine Rhinitis Virus (ERV). Specifically, four areas of interest surrounding ERV have been identified:
• Pathophysiology of ERV in the horse
• Incidence and implications of co-infection with ERV and other equine respiratory pathogens
• Incidence of ERV related to geographical location and equine discipline
• Acute/chronic effects of ERV on lower airway disease in the horse
Research proposals will be reviewed by an independent equine research review board comprised of practicing equine veterinarians and researchers. Research proposals must be submitted by Sept. 1 and will be awarded during the 2011 American Association of Equine Practitioners annual convention in San Antonio.
Proposals will be selected based on established criteria including: potential impact to the equine industry, originality and scientific quality and probability of success in completing the year-long studies.
To participate in the research award program, submit a proposal, cover letter, curriculum vitae and two letters of recommendation by Sept. 1 to:
Boehringer Ingelheim Vetmedica, Inc.
Attn: Marion Tittle
2011 Equine Research Awards
5506 Corporate Dr., Suite 1600
St. Joseph, MO 64507-7752 USA
Visit EquineDiseaseResearch.com for more information and complete submission instructions.